[Federal Register Volume 89, Number 150 (Monday, August 5, 2024)]
[Notices]
[Page 63433]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-17219]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Meeting of the Advisory Committee on Breast Cancer in Young Women

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC) announces the 
following meeting of the Advisory Committee on Breast Cancer in Young 
Women (ACBCYW). This meeting is open to the public, limited only by 
conference room space and web Conference lines (40 conference room and 
60 web conference participant spaces available). Online registration is 
required.

DATES: The meeting will be held on September 13, 2024, from 8:30 a.m. 
to 4 p.m., EDT.

ADDRESSES: 4770 Buford Highway, Atlanta, Georgia 30341, Building 106, 
Room 1B. All ACBCYW Meeting participants must register for the meeting 
online at least 5 business days in advance at https://www.cdc.gov/breast-cancer/php/advisory-committee/index.html. Please complete all 
the required fields and submit your registration no later than 
September 6, 2024. Registered participants will receive access 
instructions before the meeting. All visitors are required to present a 
valid form of picture identification issued by a state, federal or 
international government. As required by the Federal Property 
Management Regulations, all persons entering in or on Federal 
controlled property and their packages, briefcases, and other 
containers in their immediate possession are subject to being x-rayed 
and inspected. Federal law prohibits the knowing possession or the 
causing to be present of firearms, explosives and other dangerous 
weapons and illegal substances. Time will be available for public 
comment. The public is welcome to submit written comments in advance of 
the meeting. Comments should be submitted in writing by email to 
[email protected]. The deadline for receipt is September 10, 2024.

FOR FURTHER INFORMATION CONTACT: Kimberly E. Smith, M.B.A., M.H.A., 
Designated Federal Officer, Advisory Committee on Breast Cancer in 
Young Women, National Center for Chronic Disease Prevention and Health 
Promotion, Centers for Disease Control and Prevention, 4770 Buford 
Highway NE, Mailstop S107-4, Atlanta, Georgia 30341. Telephone: (404) 
498-0073; Fax: (770) 488-4760; Email: [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The Advisory Committee provides advice and guidance to the 
Secretary, HHS; the Assistant Secretary for Health; and the Director, 
CDC, regarding the formative research, development, implementation, and 
evaluation of evidence-based activities designed to prevent breast 
cancer (particularly among those at heightened risk) and promote the 
early detection and support of young women who develop the disease. The 
advice provided by the Advisory Committee will assist in ensuring 
scientific quality, timeliness, utility, and dissemination of credible 
appropriate messages and resource materials.
    Matters to be Considered: The agenda will include discussions on 
current topics related to breast cancer in young women. These will 
include Mental/Behavioral Health, Sexual Health, Genetics and Genomics, 
and Provider Engagement. Agenda items are subject to change as 
priorities dictate.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-17219 Filed 8-2-24; 8:45 am]
BILLING CODE 4163-18-P